These studies strongly suggest that the CCM2:MEKK3 interaction normally inhibits MEKK3 signalling, preventing downstream upregulation of KLF2/4 and that this is lost in CCM pathogenesis. Here, KLF2 is linked to cerebral cavernous malformation.